Literature DB >> 12755128

Enfuvirtide.

Jason LaBonte1, John Lebbos, Peter Kirkpatrick.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12755128     DOI： 10.1038/nrd1091

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  30 in total

1.  Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.

Authors:  Elisabetta Bianchi; Marco Finotto; Paolo Ingallinella; Renee Hrin; Anthony V Carella; Xiaoli S Hou; William A Schleif; Michael D Miller; Romas Geleziunas; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

Review 2.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

3.  A new lease on life for an HIV-neutralizing antibody class and vaccine target.

Authors:  Dennis R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

Review 4.  Extremophilic proteases as novel and efficient tools in short peptide synthesis.

Authors:  Aneta M Białkowska; Krzysztof Morawski; Tomasz Florczak
Journal:  J Ind Microbiol Biotechnol       Date:  2017-06-23       Impact factor: 3.346

Review 5.  T-cell antigen receptor (TCR) transmembrane peptides: A new paradigm for the treatment of autoimmune diseases.

Authors:  Nicholas Manolios; Marina Ali; Vera Bender
Journal:  Cell Adh Migr       Date:  2010-04-30       Impact factor: 3.405

6.  Viral entry inhibitors targeted to the membrane site of action.

Authors:  Matteo Porotto; Christine C Yokoyama; Laura M Palermo; Bruce Mungall; Mohamad Aljofan; Riccardo Cortese; Antonello Pessi; Anne Moscona
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 7.  HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.

Authors:  Mary Ann Checkley; Benjamin G Luttge; Eric O Freed
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

8.  Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells.

Authors:  Bárbara Gomes; Giusepinna Sanna; Silvia Madeddu; Axel Hollmann; Nuno C Santos
Journal:  ACS Infect Dis       Date:  2019-02-28       Impact factor: 5.084

9.  Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers.

Authors:  David E Martin; Robert Blum; John Wilton; Judy Doto; Hal Galbraith; Gina L Burgess; Philip C Smith; Charles Ballow
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

10.  PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

Authors:  F Li; R Goila-Gaur; K Salzwedel; N R Kilgore; M Reddick; C Matallana; A Castillo; D Zoumplis; D E Martin; J M Orenstein; G P Allaway; E O Freed; C T Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.